Fundamental Valuation Report Pfizer(PFE:NYS) Healthcare:Drug Manufacturers – General This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$39.58 (USD) 05/07/2021 Weighted Valuation$38.13 (USD) Overall RatingFairly valued to slightly Overvalued by 3.7% Valuation …

Pfizer (PFE:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Merck & Co(MRK:NYS) Healthcare:Drug Manufacturers – General This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$78.41 (USD) 05/07/2021 Weighted Valuation$79.39 (USD) Overall RatingFairly valued to slightly Undervalued by …

Merck & Co (MRK:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Gilead Sciences(GILD:NAS) Healthcare:Drug Manufacturers – General This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$63.84 (USD) 04/29/2021 Weighted Valuation$68.09 (USD) Overall RatingUndervalued by 6.7% Valuation Models Comparables: $67.83 …

Gilead Sciences (GILD:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Amgen(AMGN:NAS) Healthcare:Drug Manufacturers-Major This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$186.68 (USD) 14/02/2019 Weighted Valuation$191.24 (USD) Overall RatingFairly valued to slightly Undervalued by 2.4% Valuation Models Analyst …

Amgen (AMGN:NAS) Fundamental Valuation Report Read more »

Read More